Drug infusion systems encompass a range of devices designed to deliver precise volumes of medications, nutrients and fluids directly into a patient’s bloodstream over set intervals. These systems include infusion pumps, syringe drivers and ambulatory infusion devices, each offering benefits such as accurate flow rate control, programmable dosing schedules and alarm functions for patient safety. The advantages of drug infusion systems lie in their ability to reduce medication errors, improve therapeutic outcomes and support critical care environments, home healthcare settings and oncology treatments.

Rising prevalence of chronic diseases such as diabetes and cancer has spurred demand for continuous and controlled drug delivery solutions, while integration of smart technologies—such as wireless connectivity and data analytics—enhances remote monitoring and treatment personalization. Drug Infusion System Market providers seek to optimize workflows and adhere to stringent regulatory standards, the adoption of advanced infusion devices is positioned to grow. Moreover, improved patient compliance, reduced hospital stays and lower overall healthcare costs underscore the need for innovative infusion therapy products.

The drug infusion system market is estimated to be valued at USD 13.93 Bn in 2025 and is expected to reach USD 25.63 Bn by 2032, growing at a compound annual growth rate (CAGR) of 9.1% from 2025 to 2032.

Key Takeaways

Key players operating in the Drug Infusion System Market are B. Braun Melsungen AG, Medtronic, BD (Becton, Dickinson and Company), Fresenius Kabi AG, Baxter.

These market companies have established significant market share through strategic product launches, acquisitions and partnerships. B. Braun’s advanced volumetric infusion pumps and Medtronic’s insulin delivery systems demonstrate the competitive landscape shaping product pipelines. BD’s smart infusion platforms integrate connectivity features for real-time data, strengthening its position among healthcare providers. Fresenius Kabi’s focus on oncology infusion solutions and Baxter’s ambulatory pumps further illustrate how leading market players leverage R&D investments to expand their offerings. Continuous innovation and regulatory approvals remain central to sustaining market growth strategies for these key players and new entrants alike.

➢Get More Insights On: Drug Infusion System Market

➢Get this Report in Japanese Language: 薬剤注入システム市場

➢Get this Report in Korean Language: 약물주입시스템시장